Log In
Print
BCIQ
Print
Print this Print this
 

OI338GT (NN1953)

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionLong-acting oral insulin
Molecular Target
Mechanism of ActionInsulin receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat diabetes; Treat Type I and II diabetes; Treat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today